← Return to the complete list of publications

A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E.

Assouline S, Culjkovic-Kraljacic B, Bergeron J, Caplan S, Cocolakis E, Lambert C, Lau CJ, Zahreddine HA, Miller WH, Borden KL

Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University

Haematologica 2015;100(1):e7-9.

Pubmed ID: 25425688

Follow IRIC

Logo UdeM